Prestige Biopharma Limited sell "PBP1502 (Adalimumab biosimilar)"
Basic Information
1.2K
64
9
4.1(68)
Category
Subcategory & Sub-subcategory
Trade Type
Sell
Product Name
PBP1502 (Adalimumab biosimilar)
Manufacturer(s)
Specifications
- Regulatory Status: Phase 1 IND approved in Spain, with the clinical study currently ongoing
- Application: Biosimilar candidate for adalimumab (Humira), used to treat inflammatory conditions such as rheumatoid arthritis
- Formulation Type: Monoclonal antibody biosimilar candidate
Other Information
Additional Description:
A biosimilar candidate for adalimumab (Humira), used to treat inflammatory conditions such as rheumatoid arthritis; its Phase 1 IND has been approved in Spain and the trial is currently underway.
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment